Cargando…
Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer’s disease
Plaques that characterize Alzheimer’s disease accumulate over 20 years as a result of decreased clearance of amyloid-β peptides. Such long-lived peptides are subjected to multiple post-translational modifications, in particular isomerization. Using liquid chromatography ion mobility separations mass...
Autores principales: | Mukherjee, Soumya, Perez, Keyla A, Lago, Larissa C, Klatt, Stephan, McLean, Catriona A, Birchall, Ian E, Barnham, Kevin J, Masters, Colin L, Roberts, Blaine R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062259/ https://www.ncbi.nlm.nih.gov/pubmed/33928245 http://dx.doi.org/10.1093/braincomms/fcab028 |
Ejemplares similares
-
β-amyloid in biological samples: not all Aβ detection methods are created equal
por: Adlard, Paul A., et al.
Publicado: (2014) -
Corynoxine isomers decrease levels of amyloid-β peptide and amyloid-β precursor protein by promoting autophagy and lysosome biogenesis
por: Durairajan, Siva Sundara Kumar, et al.
Publicado: (2013) -
Amyloid β Modification: A Key to the Sporadic Alzheimer's Disease?
por: Barykin, Evgeny P., et al.
Publicado: (2017) -
Increased plasma amyloid-β(42) protein in sporadic inclusion body myositis
por: Abdo, Wilson F., et al.
Publicado: (2009) -
The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease
por: Busch, Lukas, et al.
Publicado: (2022)